Research Article
The Neutropenic Patient with Fever
Adrian Hunis MD*
Emeritus Member of ASCO, Emeritus Member of ESMO, School of Medicine. Universidad de Buenos Aires (UBA)
Adrian Hunis MD, Emeritus Member of ASCO, Emeritus Member of ESMO, School of Medicine. Universidad de Buenos Aires (UBA)
Received Date: November 18, 2021; Published Date: December 06, 2021
Abstract
Advances in chemotherapy treatments have had a significant impact on the survival of cancer patients, but they can alter the normal flora and the indemnity of natural barriers. This favors the entry of germs that are normally colonizers, making them infectious for the susceptible host. In turn, these treatments, acting on rapidly replicating cells, such as blood cells and those of the digestive tract, produce a decrease in polymorphonuclear cells with which cancer patients are more susceptible to infections.
-
Adrian Hunis MD. The Neutropenic Patient with Fever. Acad J Microbiol & Immun. 1(2): 2021. AJMI.MS.ID.000508.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.